Patents Represented by Attorney Wockcock Washburn LLP

Find this attorney in the Justia Lawyer Directory

  • PEG-modified uricase
    Patent number: 6913915
    Abstract: The present invention is directed to uricase modified with polyethylene glycol and to methods of treating different illnesses characterized by increased circulating uric acid levels, including but not limited to, hyperuricemia and tumor lysis syndrome.
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: July 5, 2005
    Assignee: Phoenix Pharmacologics, Inc.
    Inventors: Charles Mark Ensor, Mike A. Clark, Frederick Wayne Holtsberg